News - Alpha Lifetech

Home
News

Cancer-Driven Somatic Mutations Enrich Alzheimer's Disease Brain Microglia-like Macrophages, Driving Neuroinflammation and Neurodegeneration

2026-07-24 08:30

Alpha Lifetech leverages phage display and peptide library screening platforms to facilitate Alzheimer's disease target discovery and antibody development.
Complement C5: Mechanisms, Functions, and FDA-Approved Therapies

2026-07-10 20:30

C5 is a terminal complement molecule cleaved into C5a and C5b, mediating inflammation and cell lysis. Dysregulated C5 causes PNH and aHUS. Anti-C5 antibodies and aptamers block C5 cleavage.
Fine-Tuning SELEX Stringency Conditions to Improve Aptamer Affinity

2026-07-03 08:30

SELEX stringency must be actively managed across rounds. Controlled increases in washing and target pressure improve aptamer affinity, while planned stringency ramps deliver more consistent screenin...
Antigen Preparation Strategies to Maximize Immune Response Efficiency

2026-06-26 08:30

Antigen preparation impacts antibody discovery quality. Proper expression, purification, conjugation, and QC improve specificity, clone diversity, and reproducibility while reducing failedselections...
Designing Focused Peptide Libraries Based on Structural and Functional Motifs

2026-06-24 08:30

Focused peptide libraries use known motifs and smart design (alanine/positional scanning) to limit size while boosting hits. Alpha Lifetech streamlines design, synthesis, and screening.

1 2 3 4 5